[go: up one dir, main page]

BR112019002023A2 - prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticas - Google Patents

prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticas

Info

Publication number
BR112019002023A2
BR112019002023A2 BR112019002023A BR112019002023A BR112019002023A2 BR 112019002023 A2 BR112019002023 A2 BR 112019002023A2 BR 112019002023 A BR112019002023 A BR 112019002023A BR 112019002023 A BR112019002023 A BR 112019002023A BR 112019002023 A2 BR112019002023 A2 BR 112019002023A2
Authority
BR
Brazil
Prior art keywords
vectorized
prevention
treatment
probiotic bacteria
antifungal infections
Prior art date
Application number
BR112019002023A
Other languages
English (en)
Inventor
Mylonakis Eleftherios
Burgwyn Fuchs Helen
Campos Junqueira Juliana
Original Assignee
Rhode Island Hospital
Univ Estadual Paulista/Unesp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhode Island Hospital, Univ Estadual Paulista/Unesp filed Critical Rhode Island Hospital
Publication of BR112019002023A2 publication Critical patent/BR112019002023A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

a invenção refere-se a um método e composições bacterianas para reduzir ou prevenir uma infecção em um tecido do corpo por um micro-organismo fúngico por contato do tecido com uma composição compreendendo uma bactéria lactobacillus paracasei purificada.
BR112019002023A 2016-08-01 2017-07-31 prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticas BR112019002023A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662369735P 2016-08-01 2016-08-01
PCT/US2017/044703 WO2018026719A1 (en) 2016-08-01 2017-07-31 Probiotic bacteria-directed prevention or treatment of fungal infection

Publications (1)

Publication Number Publication Date
BR112019002023A2 true BR112019002023A2 (pt) 2019-05-14

Family

ID=61073083

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019002023A BR112019002023A2 (pt) 2016-08-01 2017-07-31 prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticas

Country Status (3)

Country Link
US (1) US11478516B2 (pt)
BR (1) BR112019002023A2 (pt)
WO (1) WO2018026719A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019002023A2 (pt) 2016-08-01 2019-05-14 Rhode Island Hospital prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticas
TWI718402B (zh) * 2018-08-16 2021-02-11 葡萄王生技股份有限公司 副乾酪乳酸桿菌gks6之活性物質、含其之組合物及其促進長壽之用途
WO2021148887A1 (en) * 2020-01-23 2021-07-29 Compagnie Gervais Danone Fermented plant-based probiotic compositions and processes of preparing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9084434B2 (en) * 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
CN102470151B (zh) 2009-07-16 2013-07-24 国立大学法人广岛大学 口腔内疾病的预防、改善或治疗剂
FR2984352B1 (fr) * 2011-12-16 2018-02-16 Lesaffre Et Compagnie Composition comprenant une biomasse microbienne active
US10711252B2 (en) * 2015-01-23 2020-07-14 Intralytix, Inc. Shigella bacteriophages and uses thereof
BR112019002023A2 (pt) 2016-08-01 2019-05-14 Rhode Island Hospital prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticas

Also Published As

Publication number Publication date
US11478516B2 (en) 2022-10-25
US20190151382A1 (en) 2019-05-23
WO2018026719A1 (en) 2018-02-08

Similar Documents

Publication Publication Date Title
PH12019502725A1 (en) Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety
WO2018013583A3 (en) Medicinal vaginal lactobacillus cocktail
EP4257194A3 (en) Use of microbial communities for human and animal health
EA202091389A1 (ru) Композиция на основе пробиотиков и её применение
WO2018229236A3 (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
PH12019550092A1 (en) Virulence attenuated bacteria based protein delivery
MX2017014020A (es) Terapia antimicrobiana.
BR112012033212A2 (pt) uso de lactobacillo inibindo a produção de gás de bactéria coliforme isolada em infantes afetados por cólica
BR112015026773A2 (pt) cepas bacterianas que têm atividade antimicrobiana e composições de controle biológico que compreendem as mesmas
MX2018003101A (es) Activo de polipeptidos de lisina contra bacterias gram-negativas.
MX2019007613A (es) Terapia de combinacion con compuestos ?-lactamicos sustituidos con amidina e inhibidores de ?-lactamasa para infecciones con cepas bacterianas resistentes a antibioticos.
BR112014027842A2 (pt) bacteriófago lisina e combinações de antibióticos contra bactérias gram-positivas
PH12019500360A1 (en) Antibiotic compounds
MX2018001075A (es) Agentes terapeuticos y profilacticos antibacterianos.
UA109876C2 (uk) Композиція, що містить bifidobacterium longum cncm i-2618, для лікування та профілактики імунних розладів
MX2021002719A (es) Cannabinoides para el tratamiento de infecciones grampositivas incluidas cepas bacterianas resistentes a antibióticos.
PH12019502341A1 (en) Compositions and methods involving probiotic molecules
BR112015027536A8 (pt) composição compreendendo bactérias ácidas lácticas para utilização no tratamento preventivo e/ou curativo de cistite recorrente.
ZA202002093B (en) Antibacterial compounds
BR112018014654A2 (pt) cepa inovadora de bactérias probióticas e composições e usos da mesma
MX393266B (es) Composiciónpara usarse en terapia de microbiota
BR112019002023A2 (pt) prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticas
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
WO2021004958A3 (en) Compositions comprising bacterial strains
MX2020012543A (es) Diltiazem para usarse en el tratamiento de infecciones microbianas.

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements